Drug and Therapeutics Bulletin 1994;32:12-15; doi:10.1136/dtb.1994.32212
Copyright © 1994 by the BMJ Publishing Group Ltd.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation

Prevention and treatment of Pneumocystis carinii pneumonia in patients infected with HIV

The fungus Pneumocystis carinii, which rarely if ever causes illness in otherwise healthy people, can cause potentially fatal pneumonia in patients with defects of cell-mediated immunity resulting, for example, from chemotherapy or immunosuppression after organ transplantation. P. carinii pneumonia also occurs in up to 85% of patients with acquired immunodeficiency syndrome (AIDS),1 in many of whom it is the first manifestation of the disease.2 This article discusses the prevention and treatment of P. carinii pneumonia in adults infected with the human immunodeficiency virus (HIV).






About DTB - Privacy policy - Terms and conditions relating to subscriptions purchased online - Web site terms and conditions - Feedback

© 1994 BMJ Publishing Group Ltd.